Risperdal

Risperdal® (Risperidone) is an atypical antipsychotic drug which has been linked to serious and potentially permanent side effects such as gynecomastia, the development of female breasts in boys and young men. Increases in the hormone prolactin and lactation (breasts with milk) are potentially concurrent conditions.

Attorney Matt Harman on Risperdal Gynecomastia Lawsuits:

Risperdal was originally approved by the FDA for adults suffering from schizophrenia or bipolar mania, but has been promoted and marketed so doctors increasingly prescribed it for children to treat ADHD, depression and behavioral problems– health matters for which Risperdal® did not originally have FDA approval. These “off label” uses as prescribed by physicians are not illegal, however there are allegations the drug’s manufacturer, Janssen, a division of Johnson & Johnson, withheld safety data and downplayed the gynecomastia risk.

Some boys and young men who took Risperdal developed breasts

Some boys grow just one breast, others two, and in a few cases they have grown three. The young men are embarrassed, teased, and often withdraw. The breasts can be removed surgically in a mastectomy-like procedure, but they have been known to grow back.

Gynecomastia is not the only side effect of the drug, however it is the subject of  the litigation.

Unfortunately, the Harman Law Firm is no longer accepting claims about Risperdal.